Why Moderna (MRNA) Stock Is Falling Despite Positive Clinical Results?
Moderna Inc. (MRNA) is soaring on the charts today, down -8.93% to trade at $247.90 at last check in premarket trading. On Thursday, shares in MRNA fell -3.95% to close the day at $272.21. The volume of MRNA shares traded was 5.23 million, which is lower than the average volume over the last three months …
Why Moderna (MRNA) Stock Is Falling Despite Positive Clinical Results? Read More »